Compare NUS & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NUS | USBC |
|---|---|---|
| Founded | 1984 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 242.4M | 209.6M |
| IPO Year | 1996 | 2011 |
| Metric | NUS | USBC |
|---|---|---|
| Price | $4.22 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 445.0K | 148.0K |
| Earning Date | 11-05-2026 | 08-07-2026 |
| Dividend Yield | ★ 5.85% | N/A |
| EPS Growth | ★ 207.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,176,718,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.10 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 48.98 | N/A |
| 52 Week Low | $4.10 | $0.29 |
| 52 Week High | $11.67 | $1.82 |
| Indicator | NUS | USBC |
|---|---|---|
| Relative Strength Index (RSI) | 37.29 | 43.53 |
| Support Level | N/A | $0.40 |
| Resistance Level | $4.94 | $0.54 |
| Average True Range (ATR) | 0.25 | 0.04 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 19.48 | 43.24 |
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.
USBC Inc is a multi-disciplinary technology company that is an innovator in digital financial technologies. The company develops financial services including digital assets and banking solutions, as well as non-invasive health monitoring research. USBC has implemented a Bitcoin treasury strategy to support development and research across its various divisions. A key focus is the further development of its tokenized deposit program, a tokenized representation of a U.S.-dollar-denominated bank deposit account that operates on blockchain technology and is embedded with digital identity, alongside its legacy non-invasive sensor technology business, with the objective of creating long-term shareholder value in an evolving financial landscape.